Fremeau Robert Thomas Jr. 4
4 · Vyant Bio, Inc. · Filed Nov 17, 2021
Insider Transaction Report
Form 4
Vyant Bio, Inc.VYNT
Fremeau Robert Thomas Jr.
Chief Scientific Officer
Transactions
- Award
Stock option (right to buy)
2021-11-01+250,000→ 250,000 totalExercise: $2.55Exp: 2031-11-01→ Common Stock (250,000 underlying) - Purchase
Common Stock, $0.0001 par value
2021-10-28$2.19/sh+1,000$2,190→ 1,000 total
Footnotes (1)
- [F1]The option shall become exercisable with respect to twenty five percent (25%) of the shares underlying the option on November 1, 2022, and the remaining seventy five percent (75%) of the shares underlying the option shall vest in thirty six (36) equal monthly installments commencing December 1, 2022; provided that the participant remains a service provider to the Company through each applicable vesting date